Open AccessThe natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD
Author(s) -
Giorgos Bamias,
Georgios Kokkotis,
A. Christidou,
Dimitrios Christodoulou,
Vasileios Delis,
Γεωργία Διαμαντοπούλου,
Smaragdi Fessatou,
Anthia Gatopoulou,
Όλγα Γιουλεμέ,
Panagiota Kafritsa,
Chrisostomos Kalantzis,
Andreas Kapsoritakis,
Pantelis Karatzas,
Konstantinos Karmiris,
Κωνσταντίνος Κατσάνος,
Polyxeni Kevrekidou,
Charalampos Kosmidis,
Aikaterini Mantaka,
Nicoletta Mathou,
G Michalopoulos,
Spyridon Michopoulos,
Ioannis Papaconstantinou,
George Papatheodoridis,
Dimitrios Polymeros,
Spyros Potamianos,
Georgios Poulopoulos,
Andreas Protopapas,
Maria Sklavaina,
Konstantinos Soufleris,
Georgios Theocharis,
Anǵeliki Theodoropoulou,
John K. Triantafillidis,
Konstantinos Triantafyllou,
Georgia Tsiolakidou,
Eftychia Tsironi,
Maria Tzouvala,
Nikos Viazis,
V Xourgias,
Eirini Zacharopoulou,
Evanthia Zampeli,
Gerasimos Mantzaris
Publication year - 2021
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000002267
Subject(s) - medicine , inflammatory bowel disease , epidemiology , ulcerative colitis , pandemic , crohn's disease , adverse effect , natural history , disease , population , logistic regression , covid-19 , pneumonia , infectious disease (medical specialty) , environmental health
COVID-19 has evolved into a global health crisis, variably affecting the management of patients with chronic illnesses. Patients with inflammatory bowel disease (IBD) may represent a vulnerable population due to frequent administration of immune-modifying treatments. We aimed to depict the natural history of COVID-19 infection in Greek patients with IBD at a nationwide level via unbiased reporting of all cases that were registered during the sequential waves of the pandemic.